Results 131 to 140 of about 534,463 (213)

ZBTB21 Is a Dual Suppressor of Pyroptosis and MHC-I Antigen Presentation That Promotes Tumor Immune Evasion. [PDF]

Adv Sci (Weinh)
Zhao L, Sheng L, Qiu J, Ma J, Jin K, Zhao B, Miao T, Chen J, Li Y, Zhang Z, Sun D, Li Y, Tian H.   +12 more
europepmc   +1 more source

Neutrophil Antigen Presentation Reprograms the Tumor Microenvironment and Elicits Durable and Broad Antitumor Immunity. [PDF]

Cancer Res Commun
Wang H, Meng Q, Ito Y, Kusumakar K, Mayadas T.   +4 more
europepmc   +1 more source

HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors. [PDF]

Sci Adv
Hwang D, Erdman MC, Adhikari S, Pantula R, Epstein K, Li P, Costabile F, Rotsides P, Wang CS, Sun SM, Fazelinia H, Spruce LA, Fugmann T, Rrustemi T, Soh WT, Farrel A, Want MY, Facciabene A, Mir M, Maris JM, Sgourakis NG.   +20 more
europepmc   +1 more source

Single-cell transcriptome revealed the aberrant keratinocytes activation in antigen presentation in atopic dermatitis. [PDF]

Ann Med
Liu WX, Cao Y, Chen YF, Lu YF, Xu CY, Zhai YH, Wang C, Cao Z.   +7 more
europepmc   +1 more source

Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity. [PDF]

Cancer Cell
Hu M, Liu DA, Wortzel I, Collier P, Nelson TM, Foox J, Zhong G, Tobias G, Asao T, Bojmar L, Kenific CM, Wang G, Caielli S, Wan Z, Qureshy S, Reed M, Piszczatowski R, Ravisankar P, Brown JA, Xiong S, Wang H, Lauritzen P, Aylon Y, Molina H, Jarnagin WR, Oren M, Stanger BZ, Bui J, Bergers G, Noël A, Grandgenett PM, Hollingsworth MA, Tuveson D, Boudreau N, Bromberg J, Kelsen D, Jones DR, Santambrogio L, Zeng MY, Pascual V, Kim HS, Mason CE, Zhang H, Matei IR, Lyden D.   +44 more
europepmc   +1 more source

Stress-driven remodeling of antigen presentation and chemokine signaling in pancreatic β-cells: implications for type 1 diabetes. [PDF]

Front Immunol
Mittal R, Alipour F, Doshi J, Mittal M, Hirani K.   +4 more
europepmc   +1 more source

Overcoming impaired antigen presentation in tumor-draining lymph nodes facilitates immunotherapy. [PDF]

J Immunother Cancer
O'Melia MJ, Menzel L, Lei PJ, Zhou H, Zhang X, Contreras-Alvarado N, Rajotte JJ, Liu L, Nikmaneshi MR, Baish JW, Ubellacker JM, Boland GM, Cohen S, Padera TP, Munn LL.   +14 more
europepmc   +1 more source

Ferroptotic tumor cells reprogram tumor-associated macrophage antigen presentation to enhance the efficacy of immune checkpoint blockade. [PDF]

Cell Rep Med
Sun JL, Chu YC, Wang F, Yu DD, Liu JR, Xu RC, Liu HH, Qi ZR, Shi X, Yu XN, Yao YK, Liu TT, Weng SQ, Dong L, Shen XZ, Hu SB, Sun T, Zhu JM.   +17 more
europepmc   +1 more source

DNA damage in macrophages drives immune autoreactivity via nuclear antigen presentation. [PDF]

Nat Aging
Niotis G, Arvanitaki ES, Theodorakis E, Schmalen A, Juretschke T, Argyros O, Tsolis KC, Bertsias G, Drakos E, Beli P, Garinis GA.   +10 more
europepmc   +1 more source

Correction to "Outer Membrane Vesicles from Caulobacter crescentus: A Platform for Recombinant Antigen Presentation". [PDF]

ACS Nano
Ginez LD, Osorio A, Correal-Medina V, Arenas T, González-Espinosa C, Camarena L, Poggio S.   +6 more
europepmc   +1 more source